FDA Inspection 751924 — Kabco Pharmaceuticals, Inc.

Kabco Pharmaceuticals, Inc. — FEI 2434805

The FDA completed an inspection of Kabco Pharmaceuticals, Inc. on October 21, 2011 in Amityville, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 11 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
October 21, 2011
Fiscal Year
2012
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Amityville, NY (United States)

Citations

IDCFRDescription
1544221 CFR 111.15(b)(1)Physical plant - clean and sanitary
1549421 CFR 111.25(c)Procedures - equipment - cleaning, sanitizing
1549621 CFR 111.27(b)Instruments - calibration
1557021 CFR 111.153Written procedures - components
1570221 CFR 111.320(b)Examination, testing; scientifically valid
1572321 CFR 111.365(i)Metal, foreign material
1576221 CFR 111.205(a)Master manufacturing record - each batch
1579721 CFR 111.553Written procedures - product complaint
1588621 CFR 111.77(b)Specifications not met - identity; component, reject
1597621 CFR 111.123Quality control operations - master, batch, manufacturing
1598621 CFR 111.123(b)(2)Quality control - batch, product specifications